Karen Katz - 31 Dec 2025 Form 4 Insider Report for HUMANA INC (HUM)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
05 Jan 2026, 09:31:05 UTC
Prior SEC filing
01 Oct 2025
Next SEC filing
02 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Karen W. Katz

Key filing fact

Karen Katz filed Form 4 for HUMANA INC (HUM) on 05 Jan 2026.

Key facts

  • This page summarizes Karen Katz's Form 4 filing for HUMANA INC (HUM).
  • 2 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 05 Jan 2026, 09:31.

Change

  • Previous filing in this sequence was filed on 01 Oct 2025.
  • Current net transaction value: +$12,685.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001157619 Primary reporting owner

KATZ KAREN

Relationship
Director
Address
HUMANA INC., 101 E. MAIN STREET, LOUISVILLE
Signature
Karen W. Katz
Signature date
05 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HUM holding

Humana Common

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
590
Date
31 Dec 2025
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HUM transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+766
Change %
+27%
Price
$0.000000
Shares after
3,627
Date
02 Jan 2026
Ownership
Direct
Underlying class
Humana Common
Underlying amount
766
Exercise price
Footnotes
F1
HUM transaction Derivative

Restricted Stock Units

Award

Transaction value
$12,685
Shares
+49
Change %
+65%
Price
$258.87
Shares after
124
Date
31 Dec 2025
Ownership
Direct
Underlying class
Humana Common
Underlying amount
49
Exercise price
Footnotes
F3
HUM holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
535
Date
31 Dec 2025
Ownership
Direct
Underlying class
Humana Common
Underlying amount
535
Exercise price
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan

Footnote F2

Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Footnote F3

Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .